|
|
Volumn 68, Issue 7-8, 2015, Pages 259-265
|
|
PHARMACOGENOMIC DETERMINANTS OF RESPONSE TO CARDIOVASCULAR DRUGS
a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
CARDIOVASCULAR AGENT;
CLOPIDOGREL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
TICLOPIDINE;
WARFARIN;
ANALOGS AND DERIVATIVES;
CARDIOVASCULAR DISEASES;
GENETIC SCREENING;
HUMAN;
PERSONALIZED MEDICINE;
PHARMACOGENETICS;
TREATMENT OUTCOME;
ANTICOAGULANTS;
CARDIOVASCULAR AGENTS;
CARDIOVASCULAR DISEASES;
GENETIC TESTING;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PHARMACOGENETICS;
PLATELET AGGREGATION INHIBITORS;
PRECISION MEDICINE;
TICLOPIDINE;
TREATMENT OUTCOME;
WARFARIN;
|
|
EID: 84953392702
PISSN: 00258105
EISSN: None
Source Type: Journal
DOI: 10.2298/MPNS1508259S Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|